Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 22;20(1):15.
doi: 10.1186/s12977-023-00629-4.

Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor

Joy Twentyman  1   2 , Anthony Khalifeh  3 , Abby L Felton  2 , Michael Emerman  2 , Molly Ohainle  4   5
Affiliations

Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor

Joy Twentyman et al. Retrovirology. .

Abstract

Human immunodeficiency virus (HIV) and other lentiviruses adapt to new hosts by evolving to evade host-specific innate immune proteins that differ in sequence and often viral recognition between host species. Understanding how these host antiviral proteins, called restriction factors, constrain lentivirus replication and transmission is key to understanding the emergence of pandemic viruses like HIV-1. Human TRIM34, a paralogue of the well-characterized lentiviral restriction factor TRIM5α, was previously identified by our lab via CRISPR-Cas9 screening as a restriction factor of certain HIV and SIV capsids. Here, we show that diverse primate TRIM34 orthologues from non-human primates can restrict a range of Simian Immunodeficiency Virus (SIV) capsids including SIVAGM-SAB, SIVAGM-TAN and SIVMAC capsids, which infect sabaeus monkeys, tantalus monkeys, and rhesus macaques, respectively. All primate TRIM34 orthologues tested, regardless of species of origin, were able to restrict this same subset of viral capsids. However, in all cases, this restriction also required the presence of TRIM5α. We demonstrate that TRIM5α is necessary, but not sufficient, for restriction of these capsids, and that human TRIM5α functionally interacts with TRIM34 from different species. Finally, we find that both the TRIM5α SPRY v1 loop and the TRIM34 SPRY domain are essential for TRIM34-mediated restriction. These data support a model in which TRIM34 is a broadly-conserved primate lentiviral restriction factor that acts in tandem with TRIM5α, such that together, these proteins can restrict capsids that neither can restrict alone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Diverse primate TRIM34 orthologues restrict SIVAGM-SAB, SIVAGM-SAB, and SIVMAC capsids in the presence of TRIM5α. a. THP-1 TRIM34 clonal KO cells were generated by electroporation of multiplexed sgRNA against TRIM34 and single cell sorting (ICE KO score = 96%, Additional file 1: Chromatogram S1). THP-1 TRIM34 KO cells were transduced with doxycycline-inducible HA-tagged primate TRIM34 orthologues or empty vector control. Primate TRIM34 expression was induced in the presence of 125 ng/mL doxycycline, and expression levels were visualized by immunoblotting 72 h post-induction. b-f. Primate TRIM34 expression was induced in THP-1 TRIM34 clonal KO cells. 1 day post-induction, cells were either challenged with chimeric virus particles containing HIV-1 capsids co-expressing zsGreen (b) or SIV capsids co-expressing eGFP including SIVCPZ (c), SIVAGM-SAB (d), or SIVMAC (f); or challenged with VSV-G pseudotyped SIVAGM-TAN-luc (e). Infection was quantified 2 dpi by flow cytometry (b–d, f) or luminometry (e). Relative infectivity in induced cells (white bars, circles) is normalized to average infectivity in uninduced control cells (grey bars, triangles). Fold inhibition is indicated where applicable. Infection of each cell line with each virus was performed 5-6 times across at least 2 different occasions. Combined data are represented as mean +/- s.d., where each point represents a unique infection. One-sided p values were calculated by Welch’s t-test. ns nonsignificant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 2
Fig. 2
TRIM34 requires TRIM5α to restrict SIVAGM-SAB. a–b. THP-1 TRIM34 clonal KO cells containing doxycycline-inducible TRIM34 from humans (a) or rhesus macaques (b) were transduced with lentiviral vectors encoding Cas9 and 1 of 2 independent sgRNA against TRIM5 or a non-targeting control to generate pooled TRIM5 knockout or NTC cell lines. Pooled KO efficiency was assessed by ICE analysis (Additional file 1: Chromatograms S2–S5). For human TRIM34-expressing cell lines, ICE KO efficiency scores were as follows: TRIM5 sgRNA 1 (triangles) = 76%, TRIM5 sgRNA 2 (circles) = 90%. For rhesus macaque TRIM34-expressing cells, ICE KO scores were as follows: TRIM5 sgRNA 1 (triangles) = 83%, TRIM5 sgRNA 2 (circles) = 93%. Thus, there existed 4 different experimental conditions: no TRIM34 or TRIM5α expression (black symbols), only endogenous TRIM5α expression (blue symbols), only overexpressed TRIM34 (green symbols), both endogenous TRIM5α and overexpressed TRIM34 (orange symbols). 1 day after doxycycline induction, cells were infected with SIVAGM-SAB CA particles. 2 dpi, infectivity was quantified by flow cytometry. Relative infectivity is normalized to mean infectivity in TRIM5KO, TRIM34-uninduced cells (black symbols). Infection of each cell line with each virus was performed a total of 6 times across 2 different occasions. Combined data are represented as mean +/- s.d., where each point represents a unique infection. Fold inhibition is indicated where applicable. c. HeLa cells were transduced to stably express primate TRIMΔSPRY orthologues or empty vector control. Expression was visualized by immunoblotting. d. HeLa cells stably expressing primate TRIM34ΔSPRY orthologues, human TRIM5ΔSPRY, or empty vector control were infected with N-MLV (grey bars) or NB-MLV (white bars). Level of infection was quantified 2 dpi by flow cytometry. Infection of each cell line with each virus was performed a total of 6 times across at least 2 different occasions. Combined data are represented as mean +/- s.d., where each point represents a unique infection. Fold rescue relative to empty vector control cells is indicated where applicable. a–b, d. p values were calculated by Brown-Forsythe and Welch’s 1-way ANOVA with Dunnett’s T3 test for multiple comparisons. ns nonsignificant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001
Fig. 3
Fig. 3
TRIM5α v1 loop is necessary for restriction of SIVAGM-SAB. a. THP-1 TRIM34 clonal KO cells were electroporated with multiplexed sgRNA against TRIM5. Single cell clonal lines were generated by limiting dilution to generate a THP-1 TRIM34 TRIM5 double KO clonal cell line. KO efficiency was assessed by ICE analysis (ICE KO score = 72%, Additional file 1: Chromatograms S6–S10). Cells were doubly transduced with doxycycline-inducible, HA-tagged human TRIM34 or empty vector control in tandem with doxycycline-inducible, FLAG-tagged human TRIM5α, TRIM5Δv1, TRIM5 R332P, or empty vector control. Expression was induced in the presence of 125 ng/mL doxycycline, and expression levels were visualized by immunoblotting 72 h post-induction. b–d. THP-1 TRIM34 TRIM5 double KO clonal cells co-expressing doxycycline-inducible human TRIM34 or empty vector control and human TRIM5α (grey bars), TRIM5Δv1 (orange bars), TRIM5 R332P (blue bars), or empty vector control were infected with SIVAGM-SAB (b), HIV-1 N74D (c), or HIV-1 (d) CA 1 day post-induction. Levels of infection were quantified 2 dpi by flow cytometry. Relative infectivity in induced cells (solid bars) is normalized to average infectivity in uninduced control cells (not shown). Fold inhibition is indicated where applicable. Infection of each cell line with each virus was performed a total of 6 times across 2 different occasions. Combined data are represented as mean +/- s.d., where each point represents a unique infection. One-sided p values were calculated by Welch’s t-test. ns nonsignificant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001
Fig. 4
Fig. 4
TRIM34 SPRY domain is necessary for restriction of SIVAGM-SAB. a. Schematic of TRIM34 RBCC-TRIM5 SPRY chimera. b. THP-1 TRIM34 clonal KO cells were generated by electroporation of multiplexed sgRNA against TRIM34 and single cell sorting. Cells were transduced with doxycycline-inducible HA-tagged human TRIM34, TRIM5α, or TRIM34-TRIM5α chimeras. Expression was induced in the presence of 125 ng/mL doxycycline, and expression levels were visualized by immunoblotting 72 h post-induction. c. THP-1 TRIM34 clonal KO cells expressing doxycycline-inducible human TRIM34, TRIM5α, or TRIM34 RBCC-TRIM5 SPRY were infected with SIVAGM-SAB CA or SIVAGM-TAN-luc particles 1 day post-induction. Level of infection was quantified 2 dpi by flow cytometry or luminometry, respectively. Relative infectivity in induced cells (white bars, circles) is normalized to average infectivity in uninduced control cells (grey bars, triangles). Fold inhibition is indicated where applicable. Infection of each cell line with each virus was performed a total of 6 times across 2 different occasions. Combined data are represented as mean +/- s.d., where each point represents a unique infection. One-sided p values were calculated by Welch’s t-test. ns nonsignificant, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

References

    1. Nisole S, Stoye JP, Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3:799–808. - PubMed
    1. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature. 2004;427:848–53. - PubMed
    1. Keckesova Z, Ylinen LMJ, Towers GJ. The human and african green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A. 2004;101:10780–5. - PMC - PubMed
    1. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci U S A. 2004;101:10774–9. - PMC - PubMed
    1. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor. Proc Natl Acad Sci U S A. 2006;103:5514–9. - PMC - PubMed

Publication types

Substances